These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8295363

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 24. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
    Stjernschantz J, Selén G, Astin M, Resul B.
    Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
    Shin DH, McCracken MS, Bendel RE, Pearlman R, Juzych MS, Hughes BA, Schulz LL, Kim C, Baek NH.
    Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
    [Abstract] [Full Text] [Related]

  • 27. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 28. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K, Zimmerman TJ, Downes N, Schoenfelder J, Xalacom/Latanoprost Study Group.
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [Abstract] [Full Text] [Related]

  • 29. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure.
    Friström B, Nilsson SE.
    Arch Ophthalmol; 1993 May; 111(5):662-5. PubMed ID: 8489450
    [Abstract] [Full Text] [Related]

  • 30. Prostaglandin analogs in the treatment of glaucoma.
    Hejkal TW, Camras CB.
    Semin Ophthalmol; 1999 Sep; 14(3):114-23. PubMed ID: 10790575
    [Abstract] [Full Text] [Related]

  • 31. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P.
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [Abstract] [Full Text] [Related]

  • 33. [Glaucoma therapy with prostaglandin F2 alpha derivatives].
    Diestelhorst M.
    Ophthalmologe; 1997 Oct; 94(10):754-69. PubMed ID: 9432248
    [No Abstract] [Full Text] [Related]

  • 34. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [Abstract] [Full Text] [Related]

  • 35. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF, Gagliuso DJ, Podos SM.
    J Glaucoma; 2008 Mar; 17(1):73-8. PubMed ID: 18303390
    [Abstract] [Full Text] [Related]

  • 36. Latanoprost in glaucoma associated with Sturge-Weber syndrome: benefits and side-effects.
    Altuna JC, Greenfield DS, Wand M, Liebmann JM, Taglia DP, Kaufman PL, Cioffi GA, Lee DA, Robin AL, Crichton A, Costa VP, Ritch R.
    J Glaucoma; 1999 Jun; 8(3):199-203. PubMed ID: 10376261
    [Abstract] [Full Text] [Related]

  • 37. PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.
    Villumsen J, Alm A.
    Br J Ophthalmol; 1992 Apr; 76(4):214-7. PubMed ID: 1390487
    [Abstract] [Full Text] [Related]

  • 38. Effects of prostaglandins F2 alpha, A2, and their esters in glaucomatous monkey eyes.
    Wang RF, Camras CB, Lee PY, Podos SM, Bito LZ.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2466-70. PubMed ID: 2243010
    [Abstract] [Full Text] [Related]

  • 39. Dose-related effects of prostaglandin F2 alpha isopropylester on intraocular pressure, refraction, and pupil diameter in monkeys.
    Crawford KS, Kaufman PL.
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):510-9. PubMed ID: 1878020
    [Abstract] [Full Text] [Related]

  • 40. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes.
    Gum GG, Kingsbury S, Whitley RD, Garcia A, Gelatt KN.
    J Ocul Pharmacol; 1991 Mar; 7(2):107-16. PubMed ID: 1919268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.